TRIN dividend has remained consistent for more than six years PHOENIX, March 18, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("the Company"), a leading international alternative asset manager, today announced that its Board of Directors declared a monthly regular dividend of $0.17 per share for each of April, May, and June 2026. This is an equivalent monthly distribution as the first three months of 2026.

PHOENIX, March 12, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to Monteris Medical ("Monteris"), a MedTech  company specializing in minimally invasive neurosurgical technology. Monteris Medical develops and commercializes the NeuroBlate System, a robotically controlled laser interstitial thermal therapy (LITT) platform that uses MRI-guided laser technology to remove abnormal brain tissue.

Trinity Capital continues to deliver robust financials, expanding its asset base and net investment income without increasing leverage or credit risk. TRINZ 7.875% Notes Due 2029 are likely to be called after March 2026, as TRIN shifts toward cheaper secured funding and refinancing options. Non-performing loans remain contained, and portfolio credit quality is stable, supporting the company's disciplined growth strategy.

Trinity Capital offers a covered 13.4% dividend yield, with net investment income covering 102% of its distribution. TRIN's net asset value is expanding both nominally and per share, supporting a bullish outlook amid widespread BDC dividend cuts. The recent selloff, driven by AI-related fears impacting software-backed credit, has pushed TRIN lower.

Trinity Capital Inc. (TRIN) Q4 2025 Earnings Call Transcript

Fidus Investment (FDUS) and Trinity Capital (TRIN) stand out as high-yield BDCs with differentiated strategies and disciplined risk management. FDUS focuses on lower middle-market companies, combining debt and equity investments, resulting in strong alignment and a 10% yield with robust dividend coverage. TRIN leverages internally sourced venture and equipment finance deals, utilizes interest rate floors to mitigate rate risk, and delivers a 12% yield with consistent dividend growth.

Trinity Capital earns a marginal Buy rating, driven by its attractive 13-14% yield despite elevated valuation risks. TRIN's rerating phase appears largely complete, with shares now trading at a premium (~1.08x NAV), and NAV expansion stalled since 2022. NII durability remains solid, but dividend coverage is thin; future returns hinge on credit quality and yield stability rather than further rerating.

Trinity Capital is shifting to monthly dividend distributions starting in January which is a shareholder-friendly move that has placed the security as my top income pick for 2026. Since its listing, the BDC has grown its net asset value on a nominal and per share basis at a sustained upward path. Strong 2026 GDP growth and Fed rate cuts only being brought in from the second half of next year reduce the risk TRIN faces in a pivotal year.

Hercules Capital and Trinity Capital are leading BDCs specializing in venture lending to innovation-driven small and medium businesses. As the Fed cuts interest rates, BDC companies face the risk of margin compression. However, HTGC and TRIN are better positioned to adapt to these changes, which supports my 'Buy' rating for both.

Trinity Capital stands out in the BDC space for its ~14% dividend yield, niche growth strategy, internal management, growing net investment income and rising book value. However, it faces risks, including relatively low first lien loans, relatively low floating rate debt, interest rate sensitivity and investment style. This report reviews all of the above and then concludes with my strong opinion on investing.